Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (168) Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection), Orphan Medical,
...Newly Approved Drug Therapies (168) Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection), Orphan Medical, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection) Company: Orphan Medical Approval Status: Approved October 1996 Treatment Area: meningeal leukemia or ...
View Page

2. Clinical Trial Results by Drug Names
...treatment of patients with acute/chronic renal failure or nephrotic syndrome. Secondary: To compare the electrolyte, acid-base and water balance and blood pressure normalization in patients with acute/chronic renal ...
...in status of edema pre- and post treatment. Safety parameters: Adverse events, changes of serum electrolytes. Statistical methods: Descriptive statistics were used for all the efficacy, safety and demographic variables, including ...
View Page

3.  Study Posting (4519) Trial #126403, Renal Failure, Shanghai, China
...Torem/Unat] Primary Outcome: 1. Efficacy: effectual diuresis rate. Safety: adverse events, changes in serum electrolytes. Key Secondary Outcomes: 1. Mean time to effectual diuresis, mean dosage giving effectual diuresis, change ...
View Page

4.  Study Posting (4519) Trial #126439, Renal Failure, Guangzhou, China
...Torem/Unat] Primary Outcome: 1. Efficacy: effectual diuresis rate. Safety: adverse events, changes in serum electrolytes. Key Secondary Outcomes: 1. Mean time to effectual diuresis, mean dosage giving effectual diuresis, change ...
View Page

5.  Study Posting (4519) Trial #126402, Renal Failure, Beijing, China
...Torem/Unat] Primary Outcome: 1. Efficacy: effectual diuresis rate. Safety: adverse events, changes in serum electrolytes. Key Secondary Outcomes: 1. Mean time to effectual diuresis, mean dosage giving effectual diuresis, change ...
View Page

6.  CenterWatch: New Medical Therapies in Disease Category (671), Kidney Transplantation
...the tacrolimus arm. Secondary endpoints, including incidence of new onset diabetes mellitus (NODM), kidney function, electrolytes and neurological effects, were reached as well. A statistically significant lower incidence of NODM was ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (562), Organ Transplant
...the tacrolimus arm. Secondary endpoints, including incidence of new onset diabetes mellitus (NODM), kidney function, electrolytes and neurological effects, were reached as well. A statistically significant lower incidence of NODM was ...
View Page

8.  Study Posting (1570) Trial #156482, Atrial Fibrillation, Morristown, NJ
...upper heart chambers). • Subjects who have atrial fibrillation due to a reversible cause, i.e. electrolyte imbalance. • Subjects who are current or immediate implantable cardioverter defibrillator (ICD) recipients. Kelly Colucci, Manager ...
View Page

9.  CenterWatch Clinical Research Profile (1159) Trial #557, Florida Medical Research Institute, Gainesville, FL
...Anxiolytics • Arthritis • Asthma • Bladder Dysfunction & Incontinence • CNS Agents; SSRI's • Contraceptive Agents • Contraceptive Devices • Dermatology • Electrolyte Balance • Endocrine Agents • Endometriosis • Gastrointestinal Disease • Hormone Replacement Therapy • Infectious Disease • Lice Treatment • Lipid Metabolism ...
...Cardiovascular • CNS Agents; SSRI’s • Contraceptive Agents • Contraceptive Devices • Crohn’s Disease • Depressive Disorder • Dermatology • Electrolyte Balance • Endocrine Agents • Endometriosis • Gastroesophageal Reflux Disease • Gastrointestinal Diseases • Hormone Replacement Therapy • Hypertension • Infectious Disease ...
View Page

10.  Newly Approved Drug Therapies (705) Yasmin (drospirenone/ethinyl estradiol), Berlex Laboratories,
...Yasmin users. Side Effects Drospirenone exhibits antimineralocorticoid activity that influences the regulation of water and electrolyte balance in the body. Because this activity may increase potassium levels, Yasmin should not be ...
View Page

11.  Newly Approved Drug Therapies (1023) Samsca (tolvaptan), Otsuka,
...to achieve the desired level of serum sodium. During initiation and titration, changes in serum electrolytes and volume should be frequently monitored. Co-Administration The co-administration of tolvaptan with moderate ...
View Page

12.  CenterWatch: List of Newly Approved Drug Thearapies
...Poulenc Rorer; Treatment for central diabetes insipidus, Approved February 1996 Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection) ; Orphan Medical; Treatment of meningeal leukemia or lymphocytic lymphoma, Approved October 1996 Estrostep ...
...Immunomedics; Diagnostic imaging product for colorectal cancer, Approved April 1996 Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection) ; Orphan Medical; Treatment of meningeal leukemia or lymphocytic lymphoma, Approved October 1996 Eulexin ...
View Page

13.  Study Posting (4519) Trial #149270, Diabetes Mellitus, Type 2, London, United Kingdom
...parameters, vital signs Time frame: Throughout study 2. renal function (creatinine clearance, urine volume and electrolytes) Time frame: Throughout study 3. Multiple dose pharmacokinetics of Taspoglutide Time frame: Throughout study Inclusion ...
View Page

14.  Study Posting (4519) Trial #150863, Diabetes Mellitus, Type 2, Neuss, Germany
...parameters, vital signs Time frame: Throughout study 2. renal function (creatinine clearance, urine volume and electrolytes) Time frame: Throughout study 3. Multiple dose pharmacokinetics of Taspoglutide Time frame: Throughout study Inclusion ...
View Page

15.  Study Posting (4519) Trial #149268, Diabetes Mellitus, Type 2, Berlin, Germany
...parameters, vital signs Time frame: Throughout study 2. renal function (creatinine clearance, urine volume and electrolytes) Time frame: Throughout study 3. Multiple dose pharmacokinetics of Taspoglutide Time frame: Throughout study Inclusion ...
View Page

16.  CenterWatch Clinical Research Profile (2434) Trial #1178, Northwest Louisiana Nephrology, Shreveport, LA
...patients with Chronic Kidney Disease, transplant, and HD/PD, dialysis. Clinical Research Experience • Anemia • Diabetes • Electrolyte Disorders • Glomerulonephritis • HD/PD • Hypertension • Kidney biopsies • Kidney Stone Disease • Nephrology/ Acute and Chronic Renal ...
View Page

17.  Newly Approved Drug Therapies (28) Clarithromycin (Biaxin), Abbott Laboratories,
...should not be used in subjects receiving terfenadine who have pre-existing cardiac abnormalities or electrolyte disturbances. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC. Designed by ...
View Page

18.  Newly Approved Drug Therapies (654) Micardis HCT (telmisartan and hydrochlorothiazide), Boehringer Ingelheim,
...on blood pressure. Hydrochlorothiazide is a thiazide diuretic. Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium salt and chloride in approximately equivalent amounts. Indirectly, the ...
View Page

19.  Newly Approved Drug Therapies (646) Atacand (candesartan cilexetil), AstraZeneca,
...angiotensin II synthesis. Hydrochlorothiazide is a thiazide diuretic. Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium and chloride in approximately equivalent amounts. Indirectly, the diuretic ...
View Page

20.  Newly Approved Drug Therapies (154) Aredia (pamidronate disodium for injection), Chiron,
...with antineoplastic therapy alone (12% and 23% vs. 8% and 17%, respectively). Serum calcium and electrolytes must be closely monitored, as must subjects with preexisting anemia, leukopenia, or thrombocytopenia. Additional Information ...
View Page